Matthias Fröhlich Selected Research

Matthias Fröhlich Research Topics

10	Wounds and Injuries (Trauma) 07/2021 - 04/2013
7	Multiple Trauma (Multiple Injuries) 07/2021 - 04/2013
5	Hypothermia 04/2016 - 04/2013
3	Inflammation (Inflammations) 01/2022 - 01/2014
2	Hemorrhage 12/2022 - 12/2018
2	Systemic Scleroderma (Systemic Sclerosis) 01/2021 - 01/2020
2	Acidosis 02/2020 - 04/2016
2	Hemorrhagic Shock 06/2014 - 04/2013
2	Lacerations 06/2014 - 04/2013
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 04/2023
1	Arthritis (Polyarthritis) 01/2023
1	Erdheim-Chester Disease 01/2023
1	Giant Cell Arteritis (Horton Disease) 12/2022
1	Critical Illness (Critically Ill) 12/2022
1	Osteolysis 09/2022
1	Rheumatoid Arthritis 01/2022
1	Rheumatic Diseases (Rheumatism) 11/2021
1	Birth Weight (Birth Weights) 04/2021
1	Pulmonary Arterial Hypertension 01/2021
1	Fetal Distress 09/2020
1	Tics (Tic) 08/2018
1	Multiple Organ Failure (MODS) 11/2016
1	Necrosis 01/2016
1	Shock 06/2014
1	Fibrosis (Cirrhosis) 01/2014
1	Virus Diseases (Viral Diseases) 01/2014
1	Myocarditis (Carditis) 01/2014
1	Heart Arrest (Cardiac Arrest) 04/2013
1	Thoracic Injuries (Chest Injury) 04/2013
1	Heart Failure 11/2012
1	Cardiomegaly (Heart Hypertrophy) 11/2012
1	Left Ventricular Dysfunction 11/2012
1	Hoarseness 09/2003
1	Neoplasms (Cancer) 09/2003
1	Carcinoma (Carcinomatosis) 09/2003

4	Hemostatics (Antihemorrhagics)IBA 12/2022 - 11/2015
3	salicylhydroxamic acid (SHAM)IBA 01/2016 - 04/2013
2	Glucose (Dextrose)FDA LinkGeneric 12/2022 - 11/2021
2	C-Reactive ProteinIBA 12/2022 - 01/2022
2	Interleukin-6 (Interleukin 6)IBA 06/2014 - 01/2014
1	CateninsIBA 04/2023
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 04/2023
1	Octreotide (Sandostatin)FDA LinkGeneric 04/2023
1	Somatostatin Receptors (Somatostatin Receptor)IBA 04/2023
1	upadacitinibIBA 01/2023
1	Methotrexate (Mexate)FDA LinkGeneric 01/2023
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2023
1	Biomarkers (Surrogate Marker)IBA 12/2022
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2022
1	tocilizumab (atlizumab)FDA Link 01/2022
1	Blood Alcohol ContentIBA 07/2021
1	Rituximab (Mabthera)FDA Link 01/2021
1	Tranexamic Acid (AMCA)FDA Link 01/2021
1	Indicators and Reagents (Reagents)IBA 09/2020
1	Adenosine Diphosphate (ADP)IBA 08/2018
1	RV 538 (PDMP)IBA 04/2018
1	CitrullineIBA 01/2016
1	Oxidized CelluloseIBA 11/2015
1	ChitosanIBA 11/2015
1	AlginatesIBA 11/2015
1	CollagenIBA 11/2015
1	CytokinesIBA 06/2014
1	Interleukin-8 (Interleukin 8)IBA 06/2014
1	Antiviral Agents (Antivirals)IBA 01/2014
1	ConnectinIBA 01/2014
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2014
1	Immunoglobulin G (IgG)IBA 01/2014
1	Fibrinogen (Factor I)FDA Link 04/2013
1	Sildenafil Citrate (Viagra)FDA Link 11/2012
1	Cyclic GMPIBA 11/2012
1	Angiotensin IIIBA 11/2012
1	AngiotensinsIBA 11/2012
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 11/2012

5	Induced Hypothermia 02/2020 - 04/2013
4	Therapeutics 04/2023 - 01/2022
3	Resuscitation 04/2016 - 04/2013
2	Artificial Respiration (Mechanical Ventilation) 04/2021 - 11/2016
2	Hematopoietic Stem Cell Transplantation 01/2021 - 01/2020
2	Critical Care (Surgical Intensive Care) 01/2015 - 04/2014
2	Anesthesia 06/2014 - 04/2013
1	Arthroplasty 09/2022
1	Knee Replacement Arthroplasty (Total Knee Replacement) 09/2022
1	Neonatal Intensive Care 04/2021
1	Transplantation 01/2021
1	Length of Stay 11/2016
1	Catheters 01/2014
1	Heart Transplantation (Grafting, Heart) 04/2013
1	Laryngectomy 09/2003
1	Artificial Larynx (Voice Prosthesis) 09/2003
1	Lasers (Laser) 09/2003